<code id='0829026DBD'></code><style id='0829026DBD'></style>
    • <acronym id='0829026DBD'></acronym>
      <center id='0829026DBD'><center id='0829026DBD'><tfoot id='0829026DBD'></tfoot></center><abbr id='0829026DBD'><dir id='0829026DBD'><tfoot id='0829026DBD'></tfoot><noframes id='0829026DBD'>

    • <optgroup id='0829026DBD'><strike id='0829026DBD'><sup id='0829026DBD'></sup></strike><code id='0829026DBD'></code></optgroup>
        1. <b id='0829026DBD'><label id='0829026DBD'><select id='0829026DBD'><dt id='0829026DBD'><span id='0829026DBD'></span></dt></select></label></b><u id='0829026DBD'></u>
          <i id='0829026DBD'><strike id='0829026DBD'><tt id='0829026DBD'><pre id='0829026DBD'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          comprehensive

          author:comprehensive    - browse:5
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus